Zeaxanthin Does Not Contribute to Bleeding
Zeaxanthin, a carotenoid dietary supplement found in fruits and vegetables, has no established association with increased bleeding risk and can be safely continued perioperatively.
Evidence Assessment
The provided evidence contains no guidelines, drug labels, or research studies demonstrating that zeaxanthin increases bleeding risk. The FDA drug label references 111 are for azithromycin (an antibiotic), not zeaxanthin, and are therefore irrelevant to this question.
Relevant Research Findings
Recent research actually suggests zeaxanthin may have anti-inflammatory and metabolic benefits without bleeding complications:
Metabolic effects: Zeaxanthin modulates early metabolic responses in diabetic models, affecting intestinal lipid handling and gut microbiome composition, with no reported bleeding adverse effects 2
Immunomodulatory function: Zeaxanthin enhances CD8+ T cell function and immunotherapy efficacy through TCR signaling pathways, again without bleeding-related adverse events 3
Distinction from Related Compounds
It is critical to distinguish zeaxanthin from astaxanthin, another xanthophyll carotenoid that does affect platelet function. Astaxanthin inhibits platelet aggregation, αIIbβ3 integrin activation, and prolongs bleeding time through suppression of key kinase phosphorylation pathways 4. This antiplatelet effect is not shared by zeaxanthin.
Clinical Context
The comprehensive perioperative supplement guidance from the Society for Perioperative Assessment and Quality Improvement (SPAQI) 5 does not list zeaxanthin among supplements requiring discontinuation for bleeding concerns. Supplements requiring preoperative discontinuation include those with documented antiplatelet or anticoagulant effects (e.g., garlic, ginkgo, turmeric, vitamin E).
Supplements That DO Increase Bleeding Risk
For comparison, supplements with established bleeding risk include 56:
- Omega-3 fatty acids (antithrombotic effects)
- Garlic and nattokinase (antiplatelet activity)
- Ginkgo biloba, ginger, ginseng (increased bleeding with antithrombotic therapy)
- Vitamin E (antiplatelet effects via protein kinase C inhibition)
- Curcumin/turmeric (inhibits platelet aggregation and thrombin/factor Xa generation)
Practical Recommendation
Zeaxanthin supplementation does not require discontinuation before surgery or invasive procedures and poses no increased bleeding risk when combined with anticoagulant or antiplatelet medications. Patients taking zeaxanthin for eye health (macular degeneration prevention) 7 can safely continue supplementation without bleeding concerns.